Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00566098 · OUTCOME

Anti-tumor Immune Responses

Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma · Source last updated 2023-05-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
%CD3+/CFSE-low/IFN-gamma+
Interval / dispersion
Full Range
Time frame
At time of bone marrow harvest, Day 60 post-transplant, Day 180 post-transplant, and Day 360 post-transplant

What was measured

Myeloma lysate response that measures the T-cell response quantified as %CD3+/CFSE-low/IFN-gamma+.

Groups in this outcome

MILs in Patients Undergoing an Autologous Peripheral SCT

therapeutic autologous lymphocytes therapeutic tumor infiltrating lymphocytes melphalan autologous hematopoietic stem cell transplantation

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
MILs in Patients Undergoing an Autologous Peripheral SCT22

Reported measurements

At time of bone marrow harvest
Values in %CD3+/CFSE-low/IFN-gamma+ · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
MILs in Patients Undergoing an Autologous Peripheral SCT1.58Not reported012.6Not reported
Day 60 post-transplant
Values in %CD3+/CFSE-low/IFN-gamma+ · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
MILs in Patients Undergoing an Autologous Peripheral SCT14.1Not reported044.3Not reported
Day 180 post-transplant
Values in %CD3+/CFSE-low/IFN-gamma+ · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
MILs in Patients Undergoing an Autologous Peripheral SCT18.1Not reported0.650.1Not reported
Day 360 post-transplant
Values in %CD3+/CFSE-low/IFN-gamma+ · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
MILs in Patients Undergoing an Autologous Peripheral SCT12.7Not reported031.8Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0
        upper Limit
        12.6
        value
        1.58
    title
    At time of bone marrow harvest
  2. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0
        upper Limit
        44.3
        value
        14.1
    title
    Day 60 post-transplant
  3. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0.6
        upper Limit
        50.1
        value
        18.1
    title
    Day 180 post-transplant
  4. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0
        upper Limit
        31.8
        value
        12.7
    title
    Day 360 post-transplant
denoms
  1. counts
    1. group Id
      OG000
      value
      22
    units
    Participants
description
Myeloma lysate response that measures the T-cell response quantified as %CD3+/CFSE-low/IFN-gamma+.
dispersion Type
Full Range
groups
  1. description
    therapeutic autologous lymphocytes therapeutic tumor infiltrating lymphocytes melphalan autologous hematopoietic stem cell transplantation
    id
    OG000
    title
    MILs in Patients Undergoing an Autologous Peripheral SCT
param Type
MEAN
reporting Status
POSTED
time Frame
At time of bone marrow harvest, Day 60 post-transplant, Day 180 post-transplant, and Day 360 post-transplant
title
Anti-tumor Immune Responses
type
SECONDARY
unit Of Measure
%CD3+/CFSE-low/IFN-gamma+

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice